# Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes

> **NCT01107171** · PHASE2 · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 210 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Tang-min-ling pills low dosage
- **DRUG:** Tang-min-ling pills high dosage
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01107171
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2010-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107171, "Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01107171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*